Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-26
DOI
10.1111/ajt.16324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients
- (2020) Lasse H. Jakobsen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
- (2019) O Hamid et al. ANNALS OF ONCOLOGY
- Delayed Autologous Stem Cell Transplantation Following Cardiac Transplantation Experience in Patients with Cardiac Amyloidosis
- (2019) B H Trachtenberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review
- (2019) Juliya Fisher et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
- (2019) Suzanne L. Topalian et al. JAMA Oncology
- Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis
- (2019) Devon Livingston-Rosanoff et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
- (2018) M J Maurer et al. ANNALS OF ONCOLOGY
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission
- (2018) Sergio A. Acuna et al. TRANSPLANTATION
- Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
- (2018) Clémentine Sarkozy et al. JOURNAL OF CLINICAL ONCOLOGY
- Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma
- (2018) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Case Report: Kidney Transplantation After Hematopoietic Cell Transplantation In Plasma Cell Dyscrasias
- (2018) V. Domínguez-Pimentel et al. TRANSPLANTATION PROCEEDINGS
- Long-term outcome of kidney transplantation in AL amyloidosis
- (2018) Avital Angel-Korman et al. KIDNEY INTERNATIONAL
- International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
- (2017) Matthew J. Maurer et al. JOURNAL OF CLINICAL ONCOLOGY
- Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
- (2017) Juan-Jose Lahuerta et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017
- (2017) William G. Wierda et al. Journal of the National Comprehensive Cancer Network
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
- (2016) Matthew J. Maurer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborat
- (2016) F. Zwald et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma
- (2016) Sarah T. Arron et al. DERMATOLOGIC SURGERY
- An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
- (2016) LANCET ONCOLOGY
- Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
- (2015) Matthew J. Maurer et al. AMERICAN JOURNAL OF HEMATOLOGY
- ATG-Induced Accelerated Immune Senescence: Clinical Implications in Renal Transplant Recipients
- (2015) T. Crepin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Solid organ transplant in individuals with monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia
- (2015) Paolo Strati et al. BRITISH JOURNAL OF HAEMATOLOGY
- Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
- (2015) Michele Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma Risk and Survival among Organ Transplant Recipients
- (2015) Hilary A. Robbins et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association of Antibody Induction Immunosuppression With Cancer After Kidney Transplantation
- (2015) Erin C. Hall et al. TRANSPLANTATION
- Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation
- (2014) Wai H. Lim et al. TRANSPLANTATION
- Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History
- (2013) Christina Brattström et al. TRANSPLANTATION
- Kinetics of Homeostatic Proliferation and Thymopoiesis after rATG Induction Therapy in Kidney Transplant Patients
- (2013) Anne P. Bouvy et al. TRANSPLANTATION
- Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS
- (2012) H. J. Deeg et al. BLOOD
- Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
- (2012) Leo I. Gordon et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition
- (2011) Christiane Kuschal et al. EXPERIMENTAL DERMATOLOGY
- Transmission of donor melanoma by organ transplantation
- (2010) Dirk C Strauss et al. LANCET ONCOLOGY
- Brief Report: Natural History of Individuals With Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared With Patients With Rai 0 Chronic Lymphocytic Leukemia
- (2009) Tait D. Shanafelt et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma in Organ Transplant Recipients: Clinicopathological Features and Outcome in 100 Cases
- (2008) R. N. Matin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Outcomes of melanoma in recipients of solid organ transplant
- (2008) Daniel C. Dapprich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started